Rx Up for Stimulants and Antidepressants, Down for Opioids, 2019 to 2022
By Lori Solomon HealthDay Reporter
MONDAY, Sept. 16, 2024 -- Overall prescription volumes for stimulant and antidepressant medications increased from 2019 to 2022, while prescription volume for opioids decreased, according to a study published online Sept. 13 in JAMA Network Open.
Ashwini Nagappan, from University of California, Los Angeles, and colleagues characterized in-person and telehealth prescribing patterns for stimulants, antidepressants, and opioids from 2019 to 2022. The analysis included quarterly medical and pharmacy claims from the Trilliant Health national all-payer claims database for all 50 states and the District of Columbia.
The researchers found that during the study period, prescriptions filled for stimulants increased by 37.5 percent, with the proportion prescribed from a telehealth visit growing from 1.4 percent in 2019 to 38.1 percent in 2022. While in-person stimulant prescribing rebounded from the pandemic, it remained below the pre-public health emergency average of 97.6 percent. Antidepressant prescriptions increased 20.9 percent during the study, with telehealth’s share growing from 1.5 percent to 31.4 percent. Opioid prescriptions declined before quarter 2 of 2020 and continued to decrease by 17.2 percent overall. Most opioid prescriptions were in-person visits, with telehealth prescriptions reaching 24.1 percent in quarter 2 of 2020 and leveling off at 8.4 percent in 2022, an increase from 0 percent in 2019. Women had a higher rate of telehealth prescribing across all drug types. Rural telehealth prescriptions climbed, but their share of the overall telehealth market decreased over time.
"As telehealth policies continue to evolve post-public health emergency, balancing access to prescriptions with mitigating potential risks, such as misuse, is crucial," the authors write. "Future research should compare telehealth-based and in-person prescribing appropriateness."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
Prevalence of Anxiety, Depression Explored in Youth With Chronic Pain
MONDAY, Sept. 16, 2024 -- Among youth with chronic pain, a number of individuals are diagnosed with anxiety and depression when compared with their peers without chronic pain...
Bidirectional Link Seen for Psychiatric Disorders With Chronic Rhinosinusitis
MONDAY, Sept. 16, 2024 -- There is a bidirectional association for anxiety and depression with chronic rhinosinusitis (CRS), according to a study published online Sept. 12 in JAMA...
Opt-Out Syphilis Screening in ED Improves Screening, Diagnosis
FRIDAY, Sept. 13, 2024 -- Implementation of opt-out emergency department syphilis screening leads to a dramatic increase in screening and diagnosis, especially among pregnant...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.